HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[10-year experience in the chemotherapy of epidermoid carcinomas of the upper aerodigestive system (5 protocols - 458 patients)].

Abstract
The authors report protocols and results observed with various palliative chemotherapy, used successively against epidermoid carcinomas of head and neck area. This study was followed up during the last ten years by a group of physicians working in 8 specialized oncological centers. The poor prognosis and efficiency of antimitotic drugs in head and neck carcinomas require analyse of a great number of patients files. The cooperative work of several teams allows for more rapidly significant results. Each protocol was closed after a two year period. The protocols were dropped one after another, in order to provide a greater efficiency and a lower toxicity. It was possible to confirm the limited efficiency of "heavy" protocols and the most useful association. The members of this group now pursue a randomised study comparing the results obtained with cis-platyl used alone or in addition to three other drugs. The aim of this study is to assess which is more efficient and less toxic.
AuthorsL Méeus, P Cappelaere, J Chauvergne
JournalBulletin du cancer (Bull Cancer) Vol. 70 Issue 1 Pg. 9-13 ( 1983) ISSN: 0007-4551 [Print] France
Vernacular TitleDix ans d'expérience de la chimiothérapie des carcinomes épidermoïdes des voies aéro-digestives supérieures (5 protocoles - 458 malades).
PMID6839035 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
Topics
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Carcinoma, Squamous Cell (drug therapy)
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Head and Neck Neoplasms (drug therapy)
  • Humans
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: